Ashok Leyland declares interim dividend of ₹1 per share and approves Q2 financial results

Ashok Leyland’s Board of Directors, in a meeting held on November 14, 2026, approved the unaudited standalone and consolidated financial results for the quarter and half-year ended September 30, 2026. The Board also declared an interim dividend of ₹1 per equity share of face value ₹1 each for the financial year ending March 31, 2027. The financial performance highlights include a significant increase in commercial vehicle volumes, revenue, and profit.

Ashok Leyland Declares Interim Dividend and Approves Financial Results

The Board of Directors of Ashok Leyland, at its meeting on November 14, 2026, announced the approval of the unaudited financial results for the quarter and half-year ended September 30, 2026. These results reflect a robust performance, driven by strong commercial vehicle volumes and improved revenue realization.

Financial Highlights

For the quarter ended September 30, 2026, the company reported strong growth in commercial vehicle (CV) volumes, surging 32% to 64,677 units. Revenue grew by an impressive 39% to ₹13,364 crore. Profit Before Tax (PBT) saw a 14% increase, reaching ₹1,187 crore, while Profit After Tax (PAT) grew by 13% to ₹869 crore.

Interim Dividend Declared

In a shareholder-friendly move, the Board of Directors has declared an interim dividend of ₹1 per equity share, representing 100% of the face value of ₹1 per share. This dividend is for the financial year ending March 31, 2027, and is scheduled to be paid on or before December 13, 2026. The record date for determining eligible members is November 20, 2026.

Operational Performance and Segment Growth

The company’s performance was bolstered by significant growth in both the Medium and Heavy Commercial Vehicle (MHCV) and Light Commercial Vehicle (LCV) segments. Ashok Leyland outperformed the industry in the MHCV segment with a 44% year-on-year volume growth. The domestic MHCV truck volumes saw a substantial surge of 48%, outpacing industry growth. The LCV segment also recorded healthy growth. Export volumes increased by 7% year-on-year.

Consolidated Financials and Other Disclosures

The consolidated financial results, along with the Limited Review Report, have been submitted to the stock exchanges. The document also includes disclosures regarding utilization of issue proceeds from non-convertible debentures and other relevant statements as per SEBI Listing Regulations. A disclaimer regarding forward-looking statements is included, highlighting potential risks and uncertainties.

Source: BSE

Previous Article

Vaxfab Enterprises Limited reports profit in Q2 FY27